Patrick Campbell

A new observational analysis from the University of Mississippi Medical Center is disputing the notion marijuana use increases stroke risk.

A new retrospective chart review is examining effectiveness of nitrous oxide during labor and potential predictors to conversion to other therapies.

New research from Nutrition Live Online 2020 is diving into the impact of high and low quality carbohydrates on diabetes risk.

An analysis of claims data from 2018 finds spending on diabetes-related supplies is greater than that of insulin, which accounts for nearly 20% of out-of-pocket healthcare spending.

Despite normally being associated with end of life care, new research suggest palliative care could benefit heart failure patients.

The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.

A new systematic review and meta-analysis is shedding light on the potential impact of inadequate health literacy on mortality and hospitalizations in heart failure patients.

A Q&A with Anne Fung, MD, Global Development Lead for the Port Delivery System with ranibizumab at Genentech.

A new study from the University of Rochester indicates early intervention could help preserve or even restore visual abilities in stroke patients.

Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.

The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.

Discussing the impact of COVID-19 on patients with neurologic conditions and how the rapid advent of telehealth has impacted interdisciplinary teams.

Discussing how a recently approved label update for sodium zirconium cyclosilicate impacts the treatment armamentarium of clinicians.

Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.

A new analysis of 12 randomized clinical trials is shedding more definitive light on the impact of antihypertensive agents on risk of dementia and cognitive decline.

Young Kim, PhD, discusses the use of a smartphone app that helps clinicians assess patients for anemia.

New research suggests combining agents from the 3 classes could pay major dividends in terms of event-free and overall survival.

New data presented at EAN 2020 Congress dives into the impact of sleep-wake disturbances on recurrent stroke events.

The approval of Phexxi makes it the first non-hormonal prescription gel for the prevention of pregnancy.

The move comes less than 3 months after a United States District Court for the District of Nevada invalidated 6 Vascepa patients owned by Amarin.

The Chiesi Group announced the approval in a statement on May 21.

A new analysis of the DASH trial found a fruit-and-vegetable diet was associated with lower levels of hs-cTnl and NT-proBNP.

New data from NYU Langone Health found the rate of stroke in hospitalized patients was less than 1%, much lower than the reported rate of 2-5% from other countries.

New data found an 18-year-old female patient developed subacute thyroiditis following a COVID-19 infection.

New research suggests BP during and after exercise could indicate increased risk of hypertension, cardiovascular disease, and mortality.

A new meta-analysis finds women are less likely to receive ACE inhibitors, statins, and other recommended CV medications than their male counterparts.

Discussing tips and strategies for effectively taking medical practices, especially those focused on obesity management, virtual.

Discussing the combined and respective roles of nutrition and pharmacological agents in the management of obesity.

New research from an analysis of the Rush MAP is examining associations between FGCRS and cognitive decline later in life.

A new analysis from SCAI 2020 is shedding light on the use of the Melody TPV in patients who underwent valve implantation within an existing dysfunctional right ventricular outflow tract conduit or bioprosthetic pulmonary valve.